IXHL: Incannex Healthcare Inc. Stock

by  •  • Comments Off on IXHL: Incannex Healthcare Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 41.28
Enterprise Value ($M) 35.43
Book Value ($M) 6.59
Book Value / Share 0.64
Price / Book 3.68
NCAV ($M) 5.76
NCAV / Share 0.33
Price / NCAV 7.17

Profitability (mra)
Return on Invested Capital (ROIC) -1.59
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 1.65
Current Ratio 2.88

Balance Sheet (mrq) ($M)
Current Assets 15.21
Assets 16.05
Liabilities 9.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -18.61
Net Income -18.46

Cash Flow Statement (mra) ($M)
Cash From Operations -15.85
Cash from Investing -0.28
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-09-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT T
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT T
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPOR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 9,284 73,508 12.63
2024-11-14 4,565 42,650 10.70
2024-11-13 6,061 50,905 11.91
2024-11-12 6,145 82,019 7.49

(click for more detail)

Similar Companies
IRON – Disc Medicine, Inc. ITOS – iTeos Therapeutics, Inc.
IVVD – Invivyd, Inc. JANX – Janux Therapeutics, Inc.
KALV – KalVista Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io